Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients
L. Faber et al., Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients, HEART, 83(3), 2000, pp. 326-331
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective-To determine the long term outcome in patients treated with percu
taneous transluminal septal myocardial ablation (PTSMA) for hypertrophic ob
structive cardiomyopathy (HOCM).
Design and setting-Observational, single centre study.
Patients-25 patients (13 women, 12 men, mean (SD) age 54.7 (15.0) years) wi
th drug treatment resistant New York Heart Association (NYHA) class 2.8 (0.
6) symptoms attributed to a high left ventricular outflow gradient (LVOTG)
and a coronary artery anatomy suitable for intervention.
Intervention-PTSMA by injection of 4.1 (2.6) ml of alcohol (96%) into 1.4 (
0.6) septal perforator arteries to ablate the hypertrophied interventricula
r septum.
Outcome measures-During in-hospital follow up, enzyme rise, the frequency o
f atrioventricular conduction lesions requiring permanent DDD pacing, and i
n-hospital mortality were assessed. Long term follow up (30 (4) months, ran
ge 24-36 months) included symptoms, echocardiographic measurements of left
atrial and left ventricular dimensions and function, and LVOTG.
Results-Mean postinterventional creatine kinase rise was 780 (436) U/l. Dur
ing PTSMA 13 patents developed total heart block, permanent pacing being ne
cessary in five of them. One 86 year old patient died from ventricular fibr
illation associated with intensive treatment (beta mimetic and theophylline
) for coexistent severe obstructive airway disease, After three months, thr
ee patients underwent re-PTSMA because of a dissatisfactory primary result,
leading to LVOTG elimination in all of them. During long term follow up, L
VOTG showed sustained reduction (3 (6) mm Hg at rest and 12 (19) mm Hg with
provocation) associated with stable symptomatic improvement (NYHA class 1.
2 (1.0)) and without significant global left ventricular dilatation.
Conclusions-PTSMA is an effective non-surgical technique for reduction of s
ymptoms and LVOTG in HOCM. Prospective, long term observations of larger po
pulations are necessary in order to determine the definitive significance o
f the procedure.